First Look Analysts Research Calls for Friday, January 27
This report was sent to Briefing.com subscribers earlier today. Upgrades: > Akero Therapeutics (AKRO) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $65 > Cabaletta Bio (CABA) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Akero Therapeutics (AKRO) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $65
> Cabaletta Bio (CABA) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $16
> General Mills (GIS) upgraded to Buy from Neutral at UBS; tgt raised to $88
> Iovance Biotherapeutics (IOVA) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $14
> McCormick (MKC) upgraded to Outperform from Mkt Perform at Bernstein; tgt $90
> Viatris (VTRS) upgraded to Buy from Hold at Jefferies; tgt raised to $15
Downgrades:
> Alaska Air (ALK) downgraded to Peer Perform from Outperform at Wolfe Research
> Aveanna (AVAH) downgraded to Underperform from Neutral at Credit Suisse; tgt lowered to $1
> Fortinet (FTNT) downgraded to Neutral from Buy at Mizuho; tgt $60
> Hess (HES) downgraded to Neutral from Buy at Goldman; tgt raised to $170
> Northrop Grumman (NOC) downgraded to Market Perform from Outperform at Cowen; tgt lowered to $478
> Origin Bancorp (OBNK) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $41
> Taysha Gene Therapies (TSHA) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $3
Others:
> Bill.com (BILL) initiated with a Buy at Citigroup; tgt $131
> CNH Industrial (CNHI) initiated with a Buy at Berenberg; tgt $31
> Commvault Systems (CVLT) initiated with a Buy at Guggenheim; tgt $86
> Compass Therapeutics (CMPX) initiated with a Buy at Stifel; tgt $9
> Confluent (CFLT) initiated with a Buy at Guggenheim; tgt $29
> Couchbase (BASE) initiated with a Buy at Guggenheim; tgt $20
> Driven Brands (DRVN) initiated with a Buy at The Benchmark Company; tgt $40
> Informatica (INFA) initiated with a Buy at Guggenheim; tgt $24
> MongoDB (MDB) initiated with a Neutral at Guggenheim; tgt $205
> Teradata (TDC) initiated with a Neutral at Guggenheim
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.